Biggest News Aggregation in the World
📰 Risk Evaluation News

Risk Evaluation News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Risk Evaluation. Real-time updates on events, politics, business and more.

MSNBCW Meet July 5, 2024

both sides kept their word. >> i think we did pretty dang good for the american public. >> can both parties claim victory? ill talk to democratic senator joe manchin of west virginia and mike rounds of south dakota. plus, a crowded field. former vice president mike pence, former new jersey chris christie, and north dakotas governor are all set to officially announce their 2024 bid this week. meanwhile, the 2024 gop front-runners, ron desantis and donald trump begin to attack each oth...
John Sutton Larry Value Joe Biden Kevin Mccarthy House Speaker Senator Manchin

MSNBC Alex Wagner Tonight July 6, 2024

named matthew as merrick, could rule on a case that seeks to upend access to a key component of medication abortion nationwide. that is a drug called -- the fda approved for use in september of 2000, and since then, it has been used safely by about 5 million people in the united states alone. typically, in tandem with another truck called -- now, works mifepristone by blocking the production of a hormone thats needed for pregnancy. and then it begins a miscarriage, and the two drugs wh...
Isn T Ukraine Falls Brian Bonner Alex Andrade Ali Velshi Texas Court

MSNBC Alex Wagner Tonight July 6, 2024

those drugs could be on the chopping block, courtesy of a texas court, where a trump appointed u.s. district judge, named matthew kacsmaryk, could rule on a case that seeks to upend access to a key component of medication abortion nationwide. that component is a drug called mifepristone. the fda approved it for use in september of 2000, and since then, it has been used safely by about 5 million people in the united states alone. typically, in tandem with another drug called misoprostol...
Samsung Galaxy S23 Xfinity Mobile 10g Network Medication Abortion Texas Court U S District Judge

CNN CNN Newsroom With Poppy Harlow and Jim Sciutto July 7, 2024

morning, particularly in the areas that were hard hit, just understand, this is still a hazardous situation. those folks that were in there, in the wee hours of the morning, were taking big risks as first responders navigating this. you have power lines that are down. you have trees that are down. you have a lot of hazards right now. we do anticipate a lot of the water will subside in some of the barrier islands and some of the coasts, but some of those inland places off rivers and off...
Port Charlotte Hurricane Ian Fema Has Water Line Go To Fema Gov 1 800 321 3262

FOXNEWS Jesse Watters Primetime July 2, 2024

fox news alert. welcome to a special edition of jesse>> fox waters. >> primetime. im kayleigh mcenany. and for jesse, the supreme court issuing a historic ruling today, finding s that former president trump cannot pr prosecuted for official actions taken as president, but he can for private acts. efs chief justice john roberts writing for the majority, quote, the presidentti enjoys no immunity for his unofficial acts and not everything the presiden it does is officiat >> in a six three...
Jesse Watters Jesse Watters Primetimzoo E Take A Look The Oalook He Couldn T Cut It Gas Gator

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma

Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted approval for Breyanzi ® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory mantle cell lymphoma ...
United Kingdom United States Hemophagocytic Lymphohistiocytosis Meghan Gutierrez Bristol Myers Squibb Michael Wang

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
United States South Korea Pushkar Mutha Mariat Bourlon Tycel Jovelle Phillips Tony Mok

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science